Compound Detail

CHEMBL146600

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC[C@@H](CCl)NC(=O)Nc1ccc(I)cc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL146600
Phase	Preclinical
Structure Type	MOL
InChI Key	SJKOCIGWUJAMLG-VIFPVBQESA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

352.6

MW (Da)

3.43

ALogP

HBA

HBD

41.1

PSA (Å²)

0.63

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 6 meas. best 4.2

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
K562 CHEMBL385	IC50	4.2	4.2	63000.0	1
T-24 CHEMBL614774	IC50	4.17	4.17	67000.0	1
HT-29 CHEMBL384	IC50	4.1	4.1	79000.0	1
MCF7 CHEMBL387	IC50	4.1	4.1	80000.0	1
B16 CHEMBL381	IC50	4.05	4.05	89000.0	1
L1210 CHEMBL386	IC50	4.05	4.05	90000.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
K562	IC50	=	63000.0	nM	4.2	In vitro cytotoxic activity required to inhibit human chronic myelogenous leukem...	14584955
T-24	IC50	=	67000.0	nM	4.17	In vitro cytotoxic activity required to inhibit human bladder carcinoma T24 cell...	14584955
HT-29	IC50	=	79000.0	nM	4.1	In vitro cytotoxic activity required to inhibit human colon adenocarcinoma HT-29...	14584955
MCF7	IC50	=	80000.0	nM	4.1	In vitro cytotoxic activity required to inhibit human estrogen-sensitive breast ...	14584955
B16	IC50	=	89000.0	nM	4.05	In vitro cytotoxic activity required to inhibit murine melanoma B16 cell line	14584955
L1210	IC50	=	90000.0	nM	4.05	In vitro cytotoxic activity required to inhibit murine lymphocytotic leukemia L1...	14584955

PubMed	DOI	Target Context	# Activities
14584955	10.1021/jm030908a	B16	1
14584955	10.1021/jm030908a	HT-29	1
14584955	10.1021/jm030908a	K562	1
14584955	10.1021/jm030908a	L1210	1
14584955	10.1021/jm030908a	MCF7	1
14584955	10.1021/jm030908a	T-24	1
18023585	10.1016/j.bmc.2007.11.004	HT-29	1

Data from ChEMBL 36 via Core Engine